EcoDrugPlus

Ensembl ID : ENSOKIG00005027901
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSOKIG00005020997
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSOKIG00005014459
Gene Symbol: RPS3A
1 Cross references
355 Possible Orthologues:

Ensembl ID : ENSOKIG00005039957
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOKIG00005022134
Gene Symbol: -
Cross references: -
505 Possible Orthologues:

Ensembl ID : ENSOKIG00005026938
Gene Symbol: -
Cross references: -
97 Possible Orthologues:

Ensembl ID : ENSOKIG00005033385
Gene Symbol: -
Cross references: -
97 Possible Orthologues:

Ensembl ID : ENSOKIG00005014719
Gene Symbol: -
Cross references: -
499 Possible Orthologues:

Ensembl ID : ENSOKIG00005033926
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSOKIG00005039226
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOKIG00005040443
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSOKIG00005038856
Gene Symbol: -
Cross references: -
246 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).